274 related articles for article (PubMed ID: 4202342)
1. Studies on the susceptibility of 150 consecutive clinical isolates of Pseudomonas aeruginosa to tobramycin, gentamicin, colistin, carbenicillin, and five other antimicrobials.
Lockwood WR; Lawson LA
Antimicrob Agents Chemother; 1973 Sep; 4(3):281-4. PubMed ID: 4202342
[TBL] [Abstract][Full Text] [Related]
2. Comparative in vitro activity of tobramycin, gentamicin, kanamycin, colistin, carbenicillin, and ticarcillin and clinical isolates of Pseudomonas aeruginosa: epidemiological and therapeutic implications.
Dulong de Rosnay HL; Grimont PA; Dessaut B; Lesgouarres MT
J Infect Dis; 1976 Aug; 134 Suppl():S50-6. PubMed ID: 823279
[TBL] [Abstract][Full Text] [Related]
3. In vitro sensitivity of isolates of Pseudomonas aeruginosa to carbenicillin, gentamicin, tobramycin, and some other antibiotics.
Wretland B; Nord CE; Wadström T
Scand J Infect Dis; 1974; 6(1):49-52. PubMed ID: 4208204
[No Abstract] [Full Text] [Related]
4. In vitro susceptibility of pseudomonas to four beta-lactamantibiotics (ampicillin, cephalothin, carbenicillin, piperacillin), to four aminoglycosides (kanamycin, amikacin, gentamicin, tobramycin) and to colimycin.
Hoogkamp-Korstanje JA; Westerdaal NA
Chemotherapy; 1979; 25(1):48-53. PubMed ID: 253637
[TBL] [Abstract][Full Text] [Related]
5. Susceptibility of 1,500 isolates of Pseudomonas aeruginosa to gentamicin, carbenicillin, colistin, and polymyxin B.
Duncan IB
Antimicrob Agents Chemother; 1974 Jan; 5(1):9-15. PubMed ID: 4365116
[TBL] [Abstract][Full Text] [Related]
6. Activity of newer aminoglycosides and carbenicillin, alone and in combination, against gentamicin-resistant Pseudomonas aeruginosa.
Marks MI; Hammerberg S; Greenstone G; Silver B
Antimicrob Agents Chemother; 1976 Sep; 10(3):399-401. PubMed ID: 825026
[TBL] [Abstract][Full Text] [Related]
7. Antibiotic sensitivity of two Aeromonas and nine Pseudomonas species.
Nord CE; Wadström T; Wretlind B
Med Microbiol Immunol; 1975; 161(2):89-97. PubMed ID: 1040755
[TBL] [Abstract][Full Text] [Related]
8. Susceptibility of Pseudomonas aeruginosa to tobramycin or gentamicin alone and combined with carbenicillin.
Anderson EL; Gramling PK; Vestal PR; Farrar WE
Antimicrob Agents Chemother; 1975 Sep; 8(3):300-4. PubMed ID: 810083
[TBL] [Abstract][Full Text] [Related]
9. Determination of antimicrobial susceptibility of Pseudomonas aeruginosa by disk diffusion and microdilution methods.
Cox HU; Luther DG
Am J Vet Res; 1980 Jun; 41(6):906-9. PubMed ID: 6776851
[TBL] [Abstract][Full Text] [Related]
10. Comparative activity of tobramycin, amikacin, and gentamicin alone and with carbenicillin against Pseudomonas aeruginosa.
Kluge RM; Standiford HC; Tatem B; Young VM; Greene WH; Schimpff SC; Calia FM; Hornick RB
Antimicrob Agents Chemother; 1974 Oct; 6(4):442-6. PubMed ID: 4157342
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial effectiveness ofkanamycin, aminosidin, BB-K8, sisomicin, gentamicin and tobramycin combined with carbenicillin or cephalothin against gram-negative rods.
Klastersky J; Nyamubeya B; Vandenborre L
J Med Microbiol; 1974 Nov; 7(4):465-72. PubMed ID: 4217836
[No Abstract] [Full Text] [Related]
12. Antimicrobial activity of tobramycin and gentamicin used in combination with cephalothin and carbenicillin.
Klastersky J; Henri A; Vandenborre L
Am J Med Sci; 1973 Jul; 266(1):13-21. PubMed ID: 4198684
[No Abstract] [Full Text] [Related]
13. Prevalence of Pseudomonas aeruginosa strains possessing R factor in a hospital.
Kawakami Y; Mikoshiba F; Nagasaki S; Matsumoto H; Tazaki T
J Antibiot (Tokyo); 1972 Oct; 25(10):607-9. PubMed ID: 4630693
[No Abstract] [Full Text] [Related]
14. [Isolation rate of Pseudomonas aeruginosa from clinical materials and its susceptibility to antibiotics].
Oguri T; Kosakai N
Jpn J Antibiot; 1971 Jun; 24(3):121-5. PubMed ID: 4327335
[No Abstract] [Full Text] [Related]
15. [Comparative study of the antibacterial activity of aminoglycoside antibiotics and their combinations with carbenicillin against Pseudomonas aeruginosa].
Iakushkina IV; Shapovalova SP; Malkova IV
Antibiotiki; 1982 Aug; 27(8):601-7. PubMed ID: 6812489
[TBL] [Abstract][Full Text] [Related]
16. Susceptibility of current clinical isolates of Pseudomonas aeruginosa and enteric gram-negative bacilli to amikacin and other aminoglycoside antibiotics.
Dámaso D; Moreno-López M; Martínez-Beltrán J; García-Iglesias MC
J Infect Dis; 1976 Nov; 134 SUPPL():S394-90. PubMed ID: 825591
[TBL] [Abstract][Full Text] [Related]
17. Multiresistant plasmids from Pseudomonas aeruginosa highly resistant to either or both gentamicin and carbenicillin.
Kontomichalou P; Papachristou E; Angelatou F
Antimicrob Agents Chemother; 1976 Jun; 9(6):866-73. PubMed ID: 820245
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial susceptibility of gentamicin-resistant Pseudomonas aeruginosa.
Yu PK; Washington JA
Mayo Clin Proc; 1977 Dec; 52(12):802-5. PubMed ID: 413013
[TBL] [Abstract][Full Text] [Related]
19. [Susceptibility of Pseudomonas aeruginosa recently isolated from clinical specimens to various antimicrobial agents and changes of susceptibility to carbenicillin, gentamicin and amikacin (author's transl)].
Kosakai N; Oguri T
Jpn J Antibiot; 1980 Jun; 33(6):668-74. PubMed ID: 6779031
[TBL] [Abstract][Full Text] [Related]
20. Synergy between carbenicillin and an aminoglycoside (gentamicin or tobramycin) against Pseudomonas aeruginosa isolated from patients with endocarditis and sensitivity of isolates to normal human serum.
Reyes MP; El-Khatib MR; Brown WJ; Smith F; Lerner AM
J Infect Dis; 1979 Aug; 140(2):192-202. PubMed ID: 113468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
